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Abstract
Background: ATP-binding cassette transporter A1 mediates apolipoprotein AI-dependent efflux of cholesterol and thereby
removes cholesterol from peripheral tissues. ABCA1 expression is tightly regulated and deficiency of this cholesterol
transporter results in cholesterol accumulation within cells. Low-density lipoprotein receptor-related protein 1 (LRP1)
participates in lipid metabolism and energy homeostasis by endocytosis of apolipoprotein E-containing lipoproteins and
modulation of cellular proliferation signals.
Methods and Principal Findings: In the present study, we demonstrate a new role for LRP1 in reverse cholesterol transport.
Absence of LRP1 expression results in increased PDGFRb signaling and sequential activation of the mitogen-activated
protein kinase signaling pathway, which increases phosphorylation of cytosolic phospholipase A2 (cPLA2). Phosphorylated
and activated cPLA2 releases arachidonic acid from the phospholipid pool. Overproduction of arachidonic acid suppresses
the activation of LXR/RXR heterodimers bound to the promoter of LXR regulated genes such as ABCA1, resulting in greatly
reduced ABCA1 expression.
Conclusions and Significance: LRP1 regulates LXR-mediated gene transcription and participates in reverse cholesterol
transport by controlling cPLA2 activation and ABCA1 expression. LRP1 thus functions as a physiological integrator of cellular
lipid homeostasis with signals that regulate cellular proliferation and vascular wall integrity.
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Introduction
Cholesterol is an essential component of cell membrane and
necessary for normal cellular function, including cell proliferation
[1]. Excess cholesterol accumulation, however, can result in
pathological consequences. This is particularly true for cells of the
arterial wall, where accumulation of cholesterol initiates athero-
sclerosis [2,3]. A complex homeostatic network has therefore
evolved to modulate cholesterol biosynthesis, transport and
excretion. Studies on Tangier disease have revealed an important
role of ATP-binding cassette transporter A1 (ABCA1) in
cholesterol homeostasis [4,5,6]. As a membrane transporter,
ABCA1 facilitates the formation of HDL via apolipoprotein AI
(apoAI)-mediated efflux of cholesterol and phospholipids from
many tissues [7,8,9]. This constitutes the initial step of reverse
cholesterol transport, and ultimately leads to the elimination of
cholesterol from the body [10,11,12]. Functional defects in the
ABCA1 protein that impair its ability to mediate cellular
cholesterol efflux can thus result in deposition of cholesterol
within the tissues.
As a member of the LDL receptor (LDLR) family, LDL receptor-
related protein 1 (LRP1) was initially identified as a cellular receptor
that endocytoses apolipoprotein E (apoE)-enriched lipoproteins
[13,14,15,16]. Subsequent studies have shown, however, that LRP1
is a highly multifunctional receptor that not only mediates the
endocytosis of a broad spectrum of macromolecules, but also
functions as a modulator and integrator of several fundamental cell
signalingpathways [17,18,19,20]. One oftheseinvolvessignaling by
platelet-derived growth factor BB (PDGF-BB).
LRP1 forms a complex with the PDGF receptor b (PDGFRb)i n
clathrin-coated pits and caveolae [17,21,22]. Absence of LRP1 in
vascular smooth muscle cells in the mouse (smLRP12/2) leads to
increased PDGFRb expression, greatly accelerated development
of atherosclerotic lesions, and prominent accumulation of
cholesterol in the vessel wall [18]. LRP1 also regulates Wnt5a
signaling during adipocyte differentiation and thereby serves as an
endogenous regulator of cellular cholesterol and triglyceride
homeostasis [20].
Although LRP1 and ABCA1 therefore both play import ant
and distinct roles in cellular cholesterol homeostasis and
atherosclerosis, the functional interaction between these two
membrane proteins has never been investigated. The accumula-
tion of cholesterol in the vascular wall of smLRP2/2 mice, even
in the presence of normal or only moderately increased plasma
cholesterol levels, and in particular the massive accumulation that
occurs in the absence of the LDL receptor suggested a disruption
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as a potential underlying mechanism. In the present study, we
have taken advantage of the smLRP12/2 mice to investigate the
consequences of LRP1 deficiency for ABCA1 expression and
function in vitro and in vivo. Our goal was to investigate if and how
LRP1 regulates ABCA1 functional expression and thereby
cholesterol efflux in the vascular wall.
Results
SmLRP12/2 mice have increased total cholesterol levels
in the aorta
LRP1 is a multifunctional endocytic receptor participating in
the removal of TG-rich VLDL and chylomicron remnants in the
liver [23]. Recent studies have shown that LRP1 is also involved in
cholesterol storage and fatty acid synthesis in fibroblasts and
adipocytes [20,24]. However, cholesterol levels in the aortas of
young smLRP12/2 mice in the absence of atherosclerotic lesions
have so far not been investigated. Using gas chromatography and
mass spectrometry (GC/MS), we found a significant increase in
total cholesterol in the aortas of smLRP12/2 mice (Figure 1 and
Figure S1). Only aortas lacking any morphologically discernible
atherosclerotic lesions or plaques were analyzed. These increased
cholesterol levels are thus not caused by the presence of cholesterol
in plaques or advanced lesions, but reflect either increased
lipoprotein uptake or the inability of LRP1-deficient smooth
muscle cells to export endogenous cholesterol in the presence of an
intact endothelium.
Lack of LRP1 expression in SMCs results in reduced
ABCA1 protein expression in the aorta
Because ABCA1 plays an important role in lipid transport [25],
impaired expression of ABCA1 in the aorta could potentially be
responsible for the increased total cholesterol and the enhanced
sensitivity to atherosclerosis in the smLRP12/2 mice. To
examine the expression of ABCA1 protein in wild type and
smLRP12/2 mice, we immunoblotted and immunostained the
aorta with a specific monoclonal rat anti-mouse ABCA1 antibody.
As shown in Figure 2A, a significant reduction in ABCA1 protein
in the smLRP12/2 mice was revealed by Western blotting. This
was supported by immunohistochemical staining of aorta sections,
which also showed greatly diminished ABCA1 protein in the
smLRP12/2 aortas (Figure 2B).
Increased cellular lipid accumulation is detected in LRP1-
deficient SMCs
To characterize the changes of cellular lipids in the presence
and absence of LRP1, primary SMCs were generated from the
mouse aorta. First, we confirmed by immunoblotting that ABCA1
protein levels are also significantly reduced in primary SMCs
lacking LRP1 expression (Figure 3A). We further detected an
increase in LDLR expression in the absence of LRP1. Next, we
stained the cells with Oil Red O to visualize neutral lipid deposits.
Oil Red O staining showed increased lipid accumulation in the
LRP1-deficient cells (Figure 3B, right panel). To further analyze
the components of increased lipids in the LRP12/2 SMCs, we
extracted lipids four hours after cellular uptake of
14C-labelled
oleic acid and separated the lipid extracts by thin layer
chromatography (TLC). We found increased amounts of choles-
Figure 1. GC/MS analysis of cholesterol in the mouse aorta. The
aorta from the aortic root to the iliac bifurcation was isolated, and the
surrounding connective tissue was carefully removed under a
dissecting microscope. The aorta was weighed after superficial drying
with tissue paper. Cholesterol in the aorta was determined by GC/MS
and the amount of total cholesterol (mg) was normalized by the weight
of the aorta (g). Significantly increased total cholesterol levels were
found in the aorta of the smLRP12/2 mice (black bar). 4-month old
female littermates of the indicated genotypes were used for the
depicted experiment. LRP
flox/flox animals lacking the Sm22Cre transgene
are indistinguishable from wild type [18] and were used as control
groups. Equivalent results were obtained for male mice and throughout
the lifetime of the animals (Figure S1). Values were presented as
mean6S.E.M. *p,0.05 (compared to wild type, n=3/group).
doi:10.1371/journal.pone.0006853.g001
Figure 2. Detection of ABCA1 protein expression in the aorta
by Western blotting and immunofluorescence microscopy. A.
Aortas of the indicated genotypes were homogenized in lysis buffer.
10 mg of protein extracts were subjected to 4–15% SDS-PAGE gel, and
the blot was then probed with a rat anti-mouse ABCA1 monoclonal
antibody. b-actin was detected to demonstrate equal loading. Three
independent experiments were quantitated. ABCA1 protein expression
in smLRP- aortas was reduced to 0.3960.04 compared to wild type. B.
After fixation, aortas were embedded in paraffin and 5 mm sections
were prepared. WT (left) and smLRP12/2 (right) aorta sections were
then stained with the rat anti-mouse ABCA1 monoclonal antibody, and
detected by Alexa-Fluor 568-conjugated goat anti-rat IgG (red). Images
were acquired on a Leica TCS SP confocal microscope. Scale bar: 25 mm.
Both assays showed greatly reduced ABCA1 protein expression in the
aorta of the smLRP12/2 mice.
doi:10.1371/journal.pone.0006853.g002
LRP1 Controls ABCA1 Expression
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SMCs. These data suggested that LRP1 could potentially regulate
cellular lipid trafficking by controlling ABCA1 protein expression.
LRP1 regulates ABCA1 expression at the transcriptional
level
To detect whether the reduced ABCA1 protein levels are
caused by decreased gene transcription, we next quantitated the
mRNA levels of ABCA1 and ATP-binding cassette transporter G1
(ABCG1), another transporter protein involved in cholesterol
efflux, both in WT and LRP12/2 SMCs using real-time PCR.
The result showed abundant expression of ABCA1 in primary
SMCs, whereas transcription of ABCG1 was almost undetectable
(Figure 4). Moreover, we noted a reduction of approximately 80%
in ABCA1 mRNA expression in the LRP1-deficient SMCs. This
robust decrease of ABCA1 mRNA is consistent with the significant
reduction of ABCA1 protein, suggesting that in the absence of
LRP1, ABCA1 expression is repressed at the transcriptional level.
Transcription of LXRs and RXRs is not suppressed in the
LRP-deficient SMCs
Liver X receptors (LXRs) and retinoid X receptors (RXRs) are
the key transcriptional regulators of ABCA1 [25,26]. LXRs form
obligate heterodimers with the RXRs and the heterodimers bind
to the LXR-responsive elements (LXREs) in the proximal
promoter region of ABCA1. Thus, decreased LXR and RXR
gene transcription could be responsible for the reduction in
ABCA1 mRNA levels. To examine the mRNA levels of LXRs and
RXRs in the WT and LRP12/2 SMCs, we performed real-time
PCR. Our results showed that the LXR and RXR mRNA levels in
the LRP1-deficient SMCs were comparable to those present in the
wild type cells and LXRa levels were even increased 2.4 fold
(Figure 5), suggesting that the reduced ABCA1 expression in the
LRP12/2 SMCs is not due to changes in gene transcription of
LXRs and RXRs.
Repressed ABCA1 transcription in the absence of LRP1 is
reversed by LXR agonists
Like most other nuclear receptors that form heterodimers with
RXRs, LXRs reside within the nucleus, bound to LXR response
elements (LXREs) and complexed with corepressors. In the
absence of ligand activation, these corepressors diminish the
Figure 3. Lipid analysis of primary SMCs. A. Primary SMCs of the
indicated genotypes were lysed in freshly prepared lysis buffer. 10 mgo f
protein extracts were loaded on 4–15% SDS-PAGE gels. Blots were then
probed with the rat anti-mouse ABCA1 monoclonal antibody, a rabbit
anti-LDLR polyclonal antibody, and a rabbit anti-LRP1 polyclonal
antibody. b-actin was detected to demonstrate equal loading. Western
blotting consistently confirmed significantly reduced (,5 fold) ABCA1
and increased LDLR protein expression (1.6760.12, n=3 and [36]) in
primary SMCs lacking LRP1. B. Cells grown on coverslips were fixed with
10% formalin and stained with 4 mg/ml Oil Red O in isopropyl alcohol.
Oil red O staining showed increased lipid accumulation in LRP1-
deficient cells (right panel). Images were captured on a Zeiss
fluorescence microscope. Scale bar: 12.5 mm. C. Primary SMCs of the
indicated genotypes were harvested and lysed after incubation with
14C-labelled oleic acid. Lipids were extracted with chloroform/methanol
(2:1, v:v) and processed for thin layer chromatography (TLC) analysis.
The TLC plates were exposed to a phosphor imaging plate. Cholesteryl
ester, triglycerides and free fatty acids in the lipid extracts were
separated in a solvent system consisting of hexane/ethyl ether/acetic
acid (80:20:1, v:v:v).
3H-labelled cholesterol recovery solution containing
cholesteryl oleate ester, triglyceride and oleate was used as lipid
standards. Increased amounts of cholesteryl ester and free fatty acids
were observed in LRP12/2 SMCs.
doi:10.1371/journal.pone.0006853.g003
Figure 4. Real-time PCR quantification of ABCA1 and ABCG1
mRNA in primary SMCs. 2 mg of total RNA from SMCs of the
indicated genotypes were prepared, and processed for real-time PCR.
PCR reactions were performed in triplicate. The relative amount of
mRNA was calculated using the comparative threshold cycle method.
Mouse cyclophilin mRNA was used as the invariant control. ABCA1 and
ABCG1 mRNA levels are significantly diminished in LRP1-deficient SMCs
(black bar). Wild type CT values are shown6S.D. Assays were performed
in triplicate, standard deviations are shown.
doi:10.1371/journal.pone.0006853.g004
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LXR agonist T0901317 [28] could activate the LXR/RXR
complex, we added different amounts of T0901317 to the
LRP12/2 SMCs and performed real-time PCR to follow the
transcriptional regulation of ABCA1. SREBP-1c, another LXR
target gene, was monitored for comparison. LXRa, LXRb and
cyclophilin are not regulated by LXRs and served as controls. As
shown in the Figure 6B, T0901317 potently up-regulated ABCA1
and SREBP-1c transcription already at a low concentration of
0.1 mM in the LRP1-deficient SMCs and reached its maximal
effect at about 1 mM. A similar dose-dependent response to
T0901317 was seen in the WT SMCs (Figure 6A). However, the
relative increase of ABCA1 mRNA expression was several fold
greater in the LRP12/2 SMCs than in the wild type cells.
Treatment with the LXR activator restored ABCA1 mRNA
expression to wild type levels (Figure 6C). These data suggest that
excessive repression of the LXR/RXR complex on the ABCA1
promoter, which can be overcome by treatment with an LXR
agonist, may be responsible for its reduced transcription in cells
lacking LRP1.
Because ABCA1 regulates the efflux of cellular cholesterol
through direct interaction with ApoAI [29,30], we measured
ApoAI-mediated cholesterol efflux in the WT and LRP12/2
SMCs in the presence and absence of T0901317. As we expected,
a diminished cholesterol efflux was observed in the absence of
LRP1 due to the low level of ABCA1 expression. Cholesterol
efflux increased significantly in the LRP-deficient cells following
T0901317 stimulation along with increased expression of ABCA1
(Figure 6D).
ABCA1 transcription is suppressed by LXR antagonists
Arachidonic acid can competitively antagonize T0901317-
dependent activation of the LXR [31]. To examine its effects on
the transcription of the LXR target genes ABCA1 and SREBP-1c,
we administrated different amounts of arachidonic acid to wild
type SMCs and analyzed ABCA1 transcription by real-time PCR.
Our data show that arachidonic acid strongly suppresses ABCA1
transcription already at low concentrations of 3 mM and reaches
its maximal inhibitory effect at 100 mM (Figure 7). Because the
LRP1-deficient cells accumulate more cholesteryl esters and free
fatty acids, this result suggest that excessive production of
unsaturated fatty acids could be responsible for the inhibition of
the LXR-dependent transcription in the absence of LRP1, leading
to the observed reduction in ABCA1 expression. The increase in
LXRa mRNA expression (Figure 5) may reflect a compensatory
response by the cell to counter this increased inhibition.
Loss of LRP1 function leads to cPLA2 hyper-
phosphorylation
Extracellular regulated kinase (ERK) 1/2, also called mitogen-
activated protein kinase (MAPK), has been reported to phosphor-
ylate cytosolic phospholipase A2 (cPLA2) on Ser
505, which induces
the activation of this 85 kDa cellular enzyme [32,33,34]. Activated
cPLA2 then translocates to membrane vesicles and selectively
releases arachidonic acid from the sn-2 position of membrane
phospholipids [35]. Thus, increased cPLA2 activity results in more
arachidonic acid production, and this could lead to excessive
inhibition of LXR and reduced ABCA1 transcription. To
investigate this possibility, we performed Western blotting using
a specific anti-phospho-cPLA2 (Ser
505) antibody. In the absence of
LRP1, ERK is activated as a result of increased mitogenic,
PDGFR-b mediated signaling [17,18]. Significantly increased
phosphorylation of cPLA2 was seen in the absence of LRP1 in
response to increased ERK1/2 phosphorylation (Figure 8A),
suggesting that excessive production of arachidonic acid may
indeed be responsible for the reduced expression of ABCA1 in the
absence of LRP1. To further test this hypothesis, we applied a
cPLA2a inhibitor to the LRP1-deficient SMCs and detected the
expression of ABCA1 protein by Western blotting. Consistent with
our hypothesis, ABCA1 protein levels where increased in a dose-
dependent manner by this inhibitor (Figure 8B). This result shows
that LRP1 controls cPLA2 activity, which in turn regulates the
expression of ABCA1.
Discussion
In the present study we have shown that LRP1 controls the
expression of ABCA1, a major lipid transport protein in the
plasma membrane that mediates cellular cholesterol export. Loss
of LRP1 results in greatly reduced ABCA1 protein expression,
which is caused by decreased LXR-mediated gene transcription.
Increased mitogenic signaling in the absence of LRP1 activates
ERK1/2 [17,18], which in turn stimulates cPLA2 to release
arachidonic acid, a potent LXR antagonist, from cellular
phospholipids. This potent transcriptional repression of ABCA1
occurs in cultured cells (Figure 3) as well as in the vascular wall in
vivo (Figure 2), where it results in a significant reduction of
cholesterol export from LRP1-deficient smooth muscle cells
(Figure 6D) and in the accumulation of excess cholesterol in the
aortic wall (Figure 1). Reduced ABCA1 expression in the aorta of
smLRP12/2 mice thus results in impaired cholesterol efflux and
contributes to the excessive cholesterol accumulation in vivo. This
mechanism may explain at least in part the greatly accelerated
atherosclerosis that occurs in mice lacking LRP1 specifically in
their smooth muscle cells. LRP1 thus functions as a physiological
integrator of cellular lipid homeostasis with signals that regulate
cellular proliferation and vascular wall integrity.
We observed increased accumulation of cholesterol and neutral
lipids in the aortic wall and in LRP1-deficient smooth muscle cells
(Figure 1 and 3). However, this cannot be explained entirely by
increased lipid uptake from the circulation. First, LRP1 is a
powerful lipoprotein uptake receptor, and loss of LRP1 expression
Figure 5. Quantification of LXR and RXR mRNA by real-time
PCR in primary SMCs. 2 mg of total RNA from WT and LRP12/2
SMCs were prepared and subjected to real-time PCR quantification.
Relative expression ratios represents the amount of mRNA in the
LRP12/2 SMCs relative to that in the wild type cells, which was
arbitrarily defined as 1. The number underneath each gene represented
the wild type CT values6S.D. mRNA levels of the transcriptional
regulators of ABCA1, namely LXRs and RXRs, in the LRP12/2 SMCs
(black bars) were comparable to those in the wild type cells (white
bars). Assays were performed in triplicate, standard deviations are
shown.
doi:10.1371/journal.pone.0006853.g005
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PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6853Figure 6. T0901317, a synthetic agonist of LXRs, up-regulates the expression of ABCA1. A&B. Concentration-response curves of T0901317.
WT (A) and LRP12/2 (B) SMCs were treated with the indicated concentrations of T0901317 for 48 h and mRNA levels of ABCA1 and LXRs was
subsequently determined by real-time PCR. Cyclophilin was used for normalization and SREBP-1c, a known LXR-regulatory gene [49], was added as a
positive control. T0901317 up-regulated ABCA1 transcription at a low concentration of 0.1 mM and reached its maximum effect at approximately
1 mM in the absence or presence of LRP1. C. RT-PCR analysis of ABCA1 expression in WT and LRP2/2 SMCs treated for 24 h with 5 mM T0901317. CT
values in the absence (2T) and presence (+T) of the LXR agonist are shown6S.D. Treatment of LRP2/2 SMCs with LXR agonist restored ABCA1
mRNA expression to wild type levels. Assays were performed in triplicate, standard deviations are shown. D. ApoAI-mediated cholesterol efflux was
analyzed both in WT (white bars) and LRP12/2 (black bars) SMCs in the presence and absence of T0901317 using [
3H]-labeled cholesterol.
Radioactivity released from the cell into the medium was measured by liquid scintillation counting, and cellular lipids were extracted and analyzed for
[
3H]-sterol. Data are expressed as percentage of total (cell plus medium) [
3H]-sterol released into the medium. A significant increase in apoAI-
mediated cholesterol efflux was observed in both cell lines in the presence of T0901317. ApoAI-mediated cholesterol efflux was barely detectable in
the LRP12/2 SMCs in the absence of prior T0901317 stimulation. The assay was performed in quadruplicate, and values are expressed as mean6S.D.
doi:10.1371/journal.pone.0006853.g006
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lation. On the other hand, we detected a minor compensatory
increase in the level of LDLR expression (,1.7 fold), consistent
with earlier observations in the LRP1-deficient liver [36], which
may contribute to the cholesterol elevation in LRP1 deficient
aortas of LDLR-expressing mice. However, neither increased
LDLR-mediated cholesterol uptake nor endogenous cholesterol
biosynthesis can explain the massively increased cholesterol
accumulation and atherosclerosis that occurs in smLRP- mice
that also lack functional LDL receptors [18]. Circulating plasma
lipoprotein levels are not altered by the presence or absence of
LRP1 in SMCs [18], but are primarily determined by the presence
or absence of the LDL receptor in the liver. Taken together, these
findings suggested a functional defect in cellular cholesterol export
from vascular SMCs as a potential underlying mechanism. We
therefore investigated whether the expression of ABCA1, a major
cholesterol transporter in the plasma membrane, might be altered
in the absence of LRP1. As we had suspected, ABCA1 expression
was greatly reduced in LRP1-deficient vessels as well as cultured
primary smooth muscle cells. That ABCA1 does indeed have a
significant atheroprotective role in vivo is further supported by a
recent study from the Hayden laboratory [37], which reported
tissue-specific roles of ABCA1 that influence atherosclerosis
susceptibility.
What is the mechanism by which LRP1 controls cellular ABCA1
expression and cholesterol export? ABCA1 expression is tightly
regulated at the transcriptional level, although post-transcriptional
modulation has also been described [12,25,38,39]. In this study, we
have shown that ABCA1 is down-regulated at the transcriptional
level in the absence of LRP1. Although the most important
regulators of ABCA1 expression are the nuclear hormone receptors
LXR and RXR [40,41,42] which form obligate heterodimers
bound to LXREs within its promoter [26,27], changes in the
expression levels of LXRs and RXRs cannot explain the diminished
ABCA1 expression in the absence of LRP1 (Figure 5), suggesting
that the reduced ABCA1 expression is caused by transcriptional
repression. LXR/RXR heterodimers reside in a complex with co-
repressors.Intheabsenceofactivators,thetranscriptionalactivityof
ABCA1 is repressed [27]. Binding of activators to LXR/RXR
heterodimers results in a conformational change and ABCA1
transcription[27].InFigure6wehaveshown thata syntheticligand
of LXR, T0901317 [28], is able to activate the transcription of
ABCA1, restore ABCA1 mRNA to wild type levels, and normalize
ApoAI-mediated cholesterol efflux in the LRP1-deficient SMCs.
These results suggested that in the absence of LRP1, although cells
express normal amounts of LXRs and RXRs, the LXR/RXR
heterodimers are bound to their co-repressors and are thus
functionally repressed. This explains the greatly diminished basal
expression of ABCA1 in the LRP12/2 cells. In the presence of the
synthetic ligand, the LXR/RXR heterodimers are activated and
readily induce ABCA1 transcription. The much lower baseline
expression of ABCA1 in the LRP1-deficient SMCs further
suggested, that an endogenous LXR antagonist may be responsible
for this nearly complete transcriptional repression.
TLC analysis of total cellular lipid extracts from wild type and
LRP12/2 cells showed that LRP1-deficient SMCs accumulate
Figure 7. Arachidonic acid suppresses ABCA1 expression in WT
SMCs. The indicated amount of arachidonic acid was administrated to
WT SMCs to examine its effect on the expression of ABCA1 and LXRs.
Cyclophilin was used for normalization and SREBP-1c, another LXR
target gene, was measured as a positive control. Cells were incubated
with the indicated amount of arachidonic acid for 6 h prior to real-time
PCR. Arachidonic acid potently suppressed ABCA1 transcription at a low
concentration of 3 mM and reached its maximum inhibitory effect at
100 mM.
doi:10.1371/journal.pone.0006853.g007
Figure 8. Phosphorylation of cPLA2 is markedly increased in
LRP1-deficient SMCs. A. Western blotting was performed to
determine the phosphorylation state of cPLA2 and ERK in the presence
and absence of LRP1 in primary SMCsR A significant increase in cPLA2
and ERK phosphorylation was detected using rabbit anti-phospho-
cPLA2 (Ser
505) and anti-phospho-ERK antibodies. b-actin was used as a
loading control. Five independent experiments were analyzed and
quantitated. ABCA1 protein expression in LRP12/2 was 0.2160.07,
phosphorylated cPLA2 was increased by 2.7360.35, and p-ERK1/2 was
3.3760.56 compared to LRP+/+ cells. B. cPLA2a inhibitor restores ABCA1
expression in LRP1-deficient SMCs. LRP12/2 SMCs were grown to
confluence and treated with the indicated concentrations of the cPLA2a
inhibitor (Calbiochem, Cat. No. 525143) for 24 h. Dose-dependent
increases in ABCA1 protein expression after administration of the
cPLA2a inhibitor were detected by Western blotting. b-actin was used as
a loading control.
doi:10.1371/journal.pone.0006853.g008
LRP1 Controls ABCA1 Expression
PLoS ONE | www.plosone.org 6 August 2009 | Volume 4 | Issue 8 | e6853more free fatty acids compared to wild type cells. Polyunsaturated
fattyacidsareknown tocompetitively antagonizeactivation ofLXR
by oxysterols and T0901317 [31]. To explore if an excess of
polyunsaturated fatty acids could mediate the repression of LXR-
dependent ABCA1 transcription in the absence of LRP1, we
incubated wild type SMCs with increasing concentrations of
arachidonic acid. The powerful reduction of ABCA1 and
SREBP-1c transcription in the wild type cells by administration of
exogenous arachidonic acid suggests that excessive accumulation of
polyunsaturated fatty acids in the LRP1-deficient cells could indeed
explain the observed reduction of ABCA1 expression in these cells.
As a polyunsaturated fatty acid, arachidonic acid is released from
the sn-2 position of phospholipids by phospholipase A2 (PLA2).
Mammalian cells contain several forms of PLA2 including secretory
PLA2 (sPLA2), calcium-independent PLA2, and a cytosolic cPLA2.
cPLA2 shares no homology with other PLA2 enzymes, and is the only
well characterized PLA2 that preferentially hydrolyzes arachidonic
acid from phospholipids at the sn-2 [34,43]. In addition to being
converted to potent inflammatory lipid mediators, which may
independently contribute to the increased atherosclerosis of
smLRP2/2 mice by promoting macrophage recruitment, arachi-
donic acid is itself a key regulator of cellular signaling. The importance
of arachidonic acid thus ensures that its levels are tightly controlled. As
the crucial enzyme in mediating arachidonic acid release, cPLA2 is
rapidly activated by increased concentrations of cytosolic Ca
2+ and by
serine phosphorylation [44]. cPLA2 contains a consensus sequence
(Pro-Leu-Ser
505-Pro) for phosphorylation by the MAPK ERK. ERK
efficiently phosphorylates cPLA2 at Ser
505, which increases its
enzymatic activity [32]. Previous studies have shown that loss of
LRP1 expression results in the elevated expressionof PDGFRb,whi ch
subsequently activates downstream ERK signaling [17,18,45].
Consistent with our previous findings [18], we observed increased
phosphorylation of ERK1/2 in the absence of LRP1 (Figure 8),
resulting in increased phosphorylation and activation of cPLA2,a n d
thus accelerated phospholipid and arachidonic acid turnover.
Administration of a cPLA2 inhibitor increased the expression of
ABCA1 in the LRP-deficient cells, which further supports a
mechanism by which over-production of polyunsaturated fatty acids,
including arachidonic acid, is probably the underlying cause for the
reduced ABCA1 expression in the absence of LRP1. Thus,
suppression of ABCA1 transcription in the LRP1-deficient SMCs is
likely due to repression of the LXR/RXR complexes by an
endogenously produced antagonist and this is just one example for
the altered LXR activity mediated by increased cPLA2 activity.
In summary, the present study has shown that LRP1 participates
in apoAI-mediated efflux of cholesterol and phospholipids by
controlling ABCA1 expression at the transcriptional level. These
findings further emphasize the importance of LRP1 as an integrator
of lipoprotein transport and cellular signals that regulate cell
proliferation and migration, as well as cellular lipid homeostasis.
Materials and Methods
Materials
cPLA2a inhibitor (N-{(2S,4R)-4-(Biphenyl-2-ylmethyl-isobutyl
-amino)-1-[2-(2,4-difluorobenzoyl)-benzoyl]-pyrrolidin-2-ylmethyl}-
3-[4-(2,4-dioxothiazolidin-5-ylidenemethyl)-phenyl]acrylamide, HCl)
was from Calbiochem (Cat.No. 525143).
Animals
WT and smLRP12/2 mice were maintained on a 129SvEv and
C57BL/6J hybrid background by intercrossing of Sm22Cre+;
LRP
flox/flox with hybrid LRP
flox/flox animals from the larger colony
pool to prevent allele fixation. Sex and weight-matched littermates
were used for all experiments. All mice were housed in an animal
facility with 12h light/12h dark cycles. The animals were fed a
standard rodent chow diet (Diet 7001, Harlan Teklad, Madison,
WI)andwateradlibitum.Maleandfemaleanimalsbetween2and18
months of age were used throughout the studies. No sexual
dimorphism of phenotype was observed. All procedures were
performed in accordance with the protocols approved by the
Institutional Committee for Use and Care of Laboratory Animals of
the University of Texas Southwestern Medical Center at Dallas.
Primary SMC culture
Primary mouse aortic SMCs were generated using the explant
technique as previously described [46]. Briefly, aortas were
dissected out under sterile conditions and rinsed twice with PBS.
The connective tissue and adventitia were carefully removed. The
aorta was opened longitudinally and the intima on the luminal
surface was scraped off. The aorta was then cut into small pieces
and transferred into a T25 flask containing high glucose (4.5 g/L)
DMEM supplemented with 15% fetal calf serum (FCS), 100 U/ml
penicillin and 100 mg/ml streptomycin. Outgrowing smooth
muscle cells were detached by incubation with 0.25% trypsin-
EDTA solution and cultured at 37uCi n5 %C O 2.
Analysis of cholesterol levels in mouse aorta
Sterols in the mouse aorta were analyzed by gas chromatography
and mass spectrometry (GC/MS) as previously described [47].
Briefly, the entire aorta from the aortic root to the iliac bifurcation
was dissected out and the adventitia was removed. The aorta was
weighed after superficial drying with tissue paper. Aortas were then
dissolved in 1 ml of 0.1 M NaOH and vortexed for 30 min. An
aliquot of ethanol containing the internal standards 5a-cholestane
(50 mg) and epicoprostanol (2 mg) was added to 100 ml of tissue
lysate, and sterols were hydrolyzed by heating to 100uCi n1 0 0m M
ethanolic KOH for 2 h. Lipids were extracted in petroleum ether,
dried under nitrogen, and derivatized with hexamethyldisilazane-
trimethylchlorosilane. GC/MS analysis was performed by using a
6890N gas chromatograph coupled to a 5973 mass selective
detector (Agilent Technologies, Palo Alto, CA). The trimethylsilyl-
derived sterols were separated on an HP-5MS 5%-phenyl methyl
polysiloxane capillary column (30 m60.25 mm inner diameter x
0.25 mm film) with carrier gas helium at the rate of 1 ml/min. The
temperature program was 150uC for 2 min, followed by increasing
the temperature by 20uC per min up to 280uC and holding it for
13 min. The injector was operated in the splitless mode and was
kept at 280uC. The mass spectrometer was operated in selective ion
monitoring mode. The extracted ions were 458.4 (cholesterol),
343.3 (desmosterol), 458.4 (lathosterol), 456.4 (zymosterol), 382.4
(campesterol), 393.4 (lanosterol), and 396.4 (b-sitosterol).
Western blotting
Aortas or cell pellets were homogenized in lysis buffer (1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl,
2 mM EDTA, 50 mM Tris-HCl, pH 7.5) containing freshly added
proteinase inhibitors (P8430, Sigma) and phosphatase inhibitors
(P2850 & P5726, Sigma). After centrifugationat 20,000xgfor 30 min
at 4uC, the supernatant was used for Western blotting and the pellet
was discarded. Protein extracts were separated on 4–15% SDS-
PAGEgeland transferredto nitrocellulosemembranes(HybondTM-
C Extra, RPN303 E, Amersham Biosciences). Membranes were
blocked with 5% skim milk, probed with an appropriate primary
antibody (rat anti-mouse ABCA1: NB400-164, Novus; anti-phospho-
cPLA2: 2831, Cell Signaling; anti-LDLR: 3143, Herz Lab; anti-
LRP1: 377, Herz Lab), incubated with an appropriate horseradish
peroxidase-conjugated secondary antibody (anti-rat IgG: NA9350;
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Biosciences), and then developed with an enhanced chemilumines-
cence detection kit (RPN 2132, Amersham Biosciences).
Immunofluorescence microscopy
Mice were perfusion-fixed via the left cardiac ventricle with
warmed Hank’s balanced salt solution-Hepes (20 mM, pH 7.3),
followed by the same solution containing 4% (w/v) paraformalde-
hyde. The aorta was removed and divided into small pieces. Tissues
were immersion-fixed for an additional hour followed by treatment
with a mixture of 60% (v/v) methanol, 10% (v/v) glacial acetic acid,
30% (v/v) inhibisol (1,1,1-trichloroethane) for 24 h. Tissues were
then embedded in paraffin. Paraffin sections (5 mmt h i c k )w e r e
dewaxed in three changes of xylene (10 min each), and rehydrated
into PBS (10 mM phosphate buffer, pH 7.2, 0.15 M NaCl). The
sections were washed with 50 mM NH4Cl in PBS for 30 min and
blocked by incubation for 1 h with TBS (10 mM Tris-HCl, pH 9.0,
150 mM NaCl) containing 10% (v/v) normal goat serum and 1%
(w/v) bovine serum albumin (BSA). Samples were then incubated
overnight at 4uC with a rat monoclonal antibody against mouse
ABCA1 (NB400-164, Novus) at a 1:20 dilution. Sections were
washed three times in TBS containing 0.1% BSA, and the bound
primary antibody was detected by incubation for 2 h with Alexa-
Fluor 568-conjugated goat anti-rat IgG (10 mg/ml, Molecular
Probes, Eugene, OR). The tissue slides were then washed three
times inTBS containing 0.1% BSA, rinsed with water, and mounted
on a coverslip with Fluorescence Mounting Medium (DakoCytoma-
tion). Images were taken using Leica TCS SP confocal microscope.
Oil Red O staining
Cells were grown on coverslips for two days and then fixed with
10% formalin in phosphate-buffered saline for 1 h at room
temperature. After washing three times with deionized water, cells
were stained with Oil Red O in isopropyl alcohol at a
concentration of 4 mg/ml. Finally, each coverslip was washed
for 10 min with deionized water and mounted on glass slides for
microscopic evaluation.
Lipid analysis by thin layer chromatography (TLC)
SMCs were harvested and lysed in buffer B (250 mM sucrose,
100 mM KCl, 50 mM Tris-HCl, pH 7.4) after 4 h incubation with
14C-labelled oleic acid. Part of the cell lysate was utilized for protein
measurement. Cell lysate containing equal amounts of protein was
further processed for lipid extraction by 500 ml of chloroform/
methanol (2:1, v:v). Lipid extracts were then dried and dissolved in
130 ml of chloroform/methanol (1:1, v:v). 60 ml of the lipid extracts
wereloaded(30 ml/lane, duplicate)onto a 20620 cm silica gelplate
(805013, POLYGRAM SIL G, MACHEREY-NAGEL) for
cholesterol ester, triglyceride, and free fatty acid separation by
TLC. 20 mlo f
3H-labelled cholesterol recovery solution containing
cholesterol oleate ester (30 mg), triglyceride (10 mg) and oleate
(20 mg) was used as lipid standards. Cholesteryl ester, triglyceride,
and free fatty acid separation was performed using hexane/ethyl
ether/acetic acid (80:20:1, v:v:v) as the solvent. TLC plates were
dried in a hood, and exposed to a phosphor imaging plate for 24 h
at room temperature. The imaging plate was analyzed by the Storm
820 Phosphor imager (Molecular Dynamics, Sunnyvale, CA).
Quantitative real-time PCR
Total RNA from SMCs was prepared using RNA STAT-60
from Tel-Test Inc. Equal amounts of RNA were treated with
RNAase-free DNAase I (Ambion Inc.). First-strand cDNA was
synthesized from 2 mg of DNAase I–treated total RNA with
random hexamer primers using TaqMan Reverse Transcription
Reagents (N808-0234, Applied Biosystems). Specific primers for
each gene were designed using Primer Express software (Applied
Biosystems). The real-time PCR reaction was set up in a final
volume of 20 ml containing 20 ng/ml cDNA, 2.5 mM forward and
reverse primers, and 10 ml of 2x SYBR Green PCR Master Mix
(4312704, Applied Biosystems). PCR reactions were carried out in
a 384-well plate using the ABI PRISM 7900HT Sequence
Detection System (Applied Biosystems). All reactions were done
in triplicate. The relative amount of mRNA was calculated using
the comparative threshold cycle (DDCT) method as recommended
by the manufacturer in the Applied Biosystems protocols. The
primers for real-time PCR were listed as follows: mouse ABCA1,
59-CGTTTCCGGGAAGTGTCCTA-39 (forward), 59-GCTAG-
AGATGACAAGGAGGATGGA-39 (reverse); mouse LXRa,5 9-
TCTGGAGACGTCACGGAGGTA-39 (forward), 59-CCCGGT-
TGTAACTGAAGTCCTT-39 (reverse); mouse LXRb,5 9-CTC-
CCACCCACGCTTACAC-39 (forward), 59-GCCCTAACCTC-
TCTCCACTCA-39 (reverse); mouse RXRa,5 9-CAGTACGCA-
AAGACCTGACCTACA-39 (forward), 59-GTTCCGCTGTCT-
CTTGTCGAT-39 (reverse); mouse RXRb,5 9-AAGTGTCTGG-
AGCACCTGTTCTT-39 (forward), 59-CTCCATGAGGAAG-
GTGTCAATG-39 (reverse); mouse SREBP-1c, 59-GGAGCCA-
TGGATTGCACATT-39 (forward), 59-GGCCCGGGAAGT-
CACTGT-39 (reverse); mouse cyclophilin, 59-TGGAGAGCAC-
CAAGACAGACA-39 (forward), 59-TGCCGGAGTCGACAAT-
GAT-39 (reverse). Mouse cyclophilin mRNA was used as the
invariant control.
ApoAI-mediated cholesterol efflux assay
ApoAI-mediated cholesterol efflux was analyzed as previously
described [48]. Briefly, SMCs were seeded into 16 mm wells and
radiolabeled starting at 60% confluence in high glucose (4.5 g/L)
DMEM containing 10% FCS and 0.3 mCi/ml [
3H]-cholesterol
(C8794, Sigma). Confluent cells were then loaded with 30 mg/ml
unlabeled non-lipoprotein cholesterol for 24 h, and equilibrated
for 24 h prior to 24 h incubation of 10 mg/ml apoAI. Equilibra-
tion and apoAI administration were performed in the presence or
absence of 10 mM T0901317. At the end of the incubation, media
were collected and centrifuged at 2,000 xg for 10 min to remove
cell debris. Radioactivity in the medium was measured by liquid
scintillation counting (LS-60001C, Beckman Instruments Inc.).
Cellular lipids were extracted and analyzed for [
3H]-sterol. This
assay was performed in quadruplicate. Data are expressed as
percentage of total (cell plus medium) [
3H]-sterol appearing in the
medium. Values are expressed as mean6S.D.
Statistics
Unpaired two-tail Student t-test was used for statistical analyses.
A p value , 0.05 was considered significant.
Supporting Information
Figure S1 GC/MS analysis of cholesterol in the mouse aorta.
The aorta from the aortic root to the iliac bifurcation was isolated,
and the surrounding connective tissue was carefully removed
under a dissecting microscope. The aorta was weighed after
superficial drying with tissue paper. Cholesterol in the aorta was
determined by GC/MS and the amount of total cholesterol (mg)
was normalized by the weight of the aorta (g). Increased free and
esterified cholesterol levels were found in the aorta of 18 month
old smLRP12/2 mice (compared to wildtype mice of the same
age, n=4/group).
Found at: doi:10.1371/journal.pone.0006853.s001 (0.19 MB TIF)
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